And also for the European Union how much the european fissures will get in the future to u. K. Watchers and this is one of this restocking points here if theres no deal before the end of the deadline what happens. Well i think its fair to assume that we are going to see a lot of chaos because both sides dont seem to be heard for such a worst Case Scenario then of course if there is no trade deal we are going to see tariffs on imports from the exports to the we are going to see customs checks and that could mean delays in even delivery of medicines for example we can see lanes of florries way to to cross the border and bury a lot of issues would be affected if there is no trade deal from i. V. Asian traveling in general to even you know transporting your pets from from the u. K. To the European Union. Thank you. In venezuela socialist president Nicolas Maduro has hailed a gigantic election win that hands him control of the National Assembly and cements is position and but there are soci
Good morning, everyone. Welcome to bloomberg surveillance. I am Francine Lacqua here in london. A lot going on, because we have Christine Lagarde testifying in parliament. We will bring you anything that comes out of it. The markets focusing on infections rising around the world. They are focusing around the fact that we could see a stimulus. Lets get to the markets. I dont know if we have them. If we do, it could be great, and it would be a good time to look at them. Overall,ok at stocks they are falling along u. S. Futures, tougher restrictions, progress toward a vaccine. We have plenty more of course on that. Astrazeneca at rising amidst positive news on its coronavirus vaccine. We are hearing from Christine Lagarde. We had an exclusive conversation days ago. The focus is on the need for a stimulus. The focus is also on the need for markets to do a little bit more. She said basically the ecb delivered in the first wave. She is talking about the physical packages, on course for a fis
Worked so much in the first couple of quarters. We are also expecting our investment ipo tomorrow. It is a very, very busy year for us, all in all. You are looking at health care opportunities. Everybody else seems to be doing that. That is why valuations have skyrocketed. What are you finding and what are you concentrating on within that space in particular . Nisa it is interesting. Board. St across the is, is really interesting when we invested in the first company, the first Vaccine Company to list in hong kong. One of our Companies Went out in hong kong, the first device company. Venus, thepo of whole medical device sector has become hot this year. Seen 25 areas we have Companies Getting funded in china alone. I am not sure about the competition. On the discovery side there is also excitement. Because valuation has grown so much, we would still stay away from very expensive deals. Historically, we have been investing 75 at least. Systematically we have been doing the same thing as
France threatens to get out of the rescue plan altogether. 11,000 jobs slashed, the german giant fights for survival. Welcome to the program. Looking at the futures, reflecting the way the european and u. S. Equity markets closed yesterday. Futures down in europe, mixed in the u. S. , reflecting what we saw yesterday were the u. S. Wobbled into the close at the end of the session. New york schools closing seems to be the factor. Breaking news, some commentary from astrazeneca in connection phasehase two, not the three news we have been waiting for. That is expected to come within weeks. This is more detail on the phase two data. They are confirming the vaccines immune response in older adults, that is crucial considering who is most vulnerable to the virus. The lancet is publishing the findings. A lot of stuff we have heard already from phase three trials more advanced than this from other drug companies. It has not been peerreviewed or in journals. We are getting the phase two study,
And welcome to power lunch. Im melissa lee. Check out this rally right now all 11 sectors are in gree green. Taking a look at some of the stocks were watching. Salesforce is under pressure for the second day in a row, down about 7 in the last week as it gets set to report earnings after the bell and reportedly to make a deal. And we have exclusive data on how the bitcoin boom is boosting this payment stock first lets get over to bob for more on todays rally. Hey, bob hello, melissa. Good start to a traditionally good month we got talk about a new stimulus plan, janet yellen on the air and, overall, 11 sectors all on the up side. Bank stocks leading the way but technical stocks also. No dig selloff in tech that was also a november play there. Theres energy you have your value play with banks, energy up you have your growth play with tech, cyclical with industrials up and even more defensive groups, Consumer Staples on the up side as well. This is what i mean when i say the goldie locks